ImmunoPrecise Antibodies Ltd.
IPA
$0.3918
-$0.0082-2.05%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.54M | 2.83M | 2.52M | 4.64M | 4.33M |
| Total Receivables | 3.81M | 2.55M | 3.26M | 3.35M | 3.64M |
| Inventory | 1.44M | 1.35M | 1.56M | 1.89M | 1.77M |
| Prepaid Expenses | 1.19M | 1.25M | 1.02M | 1.38M | 1.36M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.97M | 7.98M | 8.36M | 11.25M | 11.09M |
|
|
|||||
| Total Current Assets | 8.97M | 7.98M | 8.36M | 11.25M | 11.09M |
| Net Property, Plant & Equipment | 11.45M | 11.90M | 12.15M | 12.37M | 8.54M |
| Long-term Investments | 5.68M | 5.68M | 5.59M | 13.95M | 13.62M |
| Goodwill | 5.68M | 5.68M | 5.59M | 13.95M | 13.62M |
| Total Other Intangibles | 16.51M | 16.96M | 17.14M | 20.81M | 20.84M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 414.10K | 414.10K | 408.20K | 431.30K | 343.40K |
| Total Assets | 43.03M | 42.93M | 43.65M | 58.81M | 54.44M |
|
|
|||||
| Total Accounts Payable | 2.57M | 3.27M | 2.96M | 2.39M | 1.95M |
| Total Accrued Expenses | 1.29M | 217.20K | 620.60K | 1.20M | 1.01M |
| Short-term Debt | 2.22M | 1.88M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.19M | 1.16M | 1.14M | 1.32M | 686.90K |
| Total Finance Division Other Current Liabilities | 1.63M | 1.56M | 1.19M | 1.89M | 1.78M |
| Total Other Current Liabilities | 1.63M | 1.56M | 1.19M | 1.89M | 1.78M |
| Total Current Liabilities | 8.90M | 8.09M | 5.91M | 6.79M | 5.42M |
|
|
|||||
| Total Current Liabilities | 8.90M | 8.09M | 5.91M | 6.79M | 5.42M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 2.22M | 1.88M | -- | -- | -- |
| Capital Leases | 8.37M | 8.61M | 8.82M | 9.44M | 6.21M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.30M | 2.44M | 4.24M | 5.35M | 5.34M |
| Total Liabilities | 19.58M | 19.14M | 18.97M | 21.58M | 16.97M |
|
|
|||||
| Common Stock & APIC | 96.89M | 96.15M | 96.16M | 97.54M | 93.16M |
| Retained Earnings | -75.43M | -74.25M | -72.95M | -61.46M | -57.08M |
| Treasury Stock & Other | 1.99M | 1.88M | 1.47M | 1.15M | 1.39M |
| Total Common Equity | 23.45M | 23.78M | 24.68M | 37.24M | 37.46M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 23.45M | 23.78M | 24.68M | 37.24M | 37.46M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 23.45M | 23.78M | 24.68M | 37.24M | 37.46M |
|
|
|||||
